Role of Hyaluronan Metabolism in the Initiation, Invasion, and Metastasis of Breast Cancer

Hyaluronan in Cancer Biology

Volumn , Issue , 2009, Pages 341-360

  Brown, Tracey J ^a   Thomas, Natalie K ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882503385     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012374178-3.10018-3     Document Type: Chapter

References (111)

1. Afify A.M., Stern M., Guntenhoener M., Stern R. Purification and characterization of human serum hyaluronidase. Arch Biochem Biophys 1993, 305:434-441.
2. Al-Hajj M., Wicha M.S., Benito-Hernandez A., Morrison S.J., Clarke M.F. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 2003, 100:6890-6899.
3. Allred D.C., Fuqua S.A. Histological and biological evolution of human premalignant breast disease. Endocr Relat Cancer 2001, 8:47-61.
4. Auvinen P., Tammi R., Parkkinen J., et al. Hyaluronan in peritumoral stroma and malignant cells associates with breast cancer spreading and predicts survival. Am J Pathol 2000, 156:529-536.
5. Bendre M.S., Gaddy-Kurten D., Mon-Foote T., et al. Expression of interleukin 8 and not parathyroid hormone-related protein by human breast cancer cells correlates with bone metastasis. in vivo. Cancer Res 2002, 62:5571-5579.
6. Bertrand P., Girard N., Delpech B., et al. Hyaluronan (hyaluronic acid) and hyaluronectin in the extracellular matrix of human breast carcinomas: comparison between invasive and non-invasive areas. Int J Cancer 1992, 52:1-6.
7. Bharadwaj A.G., Rector K., Simpson M.A. Inducible hyaluronan production reveals differential effects on prostate tumor cell growth and tumor angiogenesis. J Biol Chem 2007, 282:20561-20572.
8. Bhowmick N.A., Moses H.L. Tumor-stroma interactions. Curr Opin Genet Dev 2005, 15:97-101.
9. Bissell M.J., Radisky D.C., Rizki A., Weaver V.M., Petersen O.W. The organizing principle: microenvironmental influences in the normal and malignant breast. Differentiation 2002, 70:537-546.
10. Bose N., Masellis A. Secretory products of breast cancer cells upregulate hyaluronan production in a human osteoblast cell line. Clin Exp Met 2005, 22:629-642.
11. Burstein H.J., Polyak K., Wong J.S., Lester S.C., Kaelin C.M. Ductal carcinoma in situ of the breast. N Engl J Med 2004, 350:1430-1441.
12. Cherr A.I.Y., Li M.W., Overstreet J.W. Hyaluronic acid and the cumulus extracellular matrix induce increases in intracellular calcium in macaque sperm via the plasma membrane protein PH-20. Zygote 1999, 7:211-222.
13. Cook A.C., Chambers A.F., Turley E.A., Tuck A.B. Osteopontin induction of hyaluronan synthase 2 expression promotes breast cancer malignancy. J Biol Chem 2006, 281:24381-24389.
14. Culty M., Underhill C.B. The hyaluronan receptor (CD44) participates in the uptake and degradation of hyaluronan. J Cell Biol 1992, 116:55-62.
15. Culty M., Thompson E.W., Underhill C.B. Binding and degradation of hyaluronan by human breast cancer cell lines expressing different forms of CD44: correlation with invasive potential. J Cell Physiol 1994, 160:275-286.
16. Dandachi N., Hauser-Kronberger C., Moré E., et al. Co-expression of tenascin-C and vimentin in human breast cancer cells indicates phenotypic transdifferentiation during tumour progression: correlation with histopathological parameters, hormone receptors, and oncoproteins. J Pathol 2001, 193:181-189.
17. Day A.J., de la Motte C.A. Hyaluronan cross-linking: a protective mechanism in inflammation?. Trends Immunol 2005, 26:637-643.
18. Delpech B., Chevallier B., Reinhardt N., et al. Serum hyaluronan (hyaluronic acid) in breast cancer patients. Int J Cancer 1990, 46:388-390.
19. Dickson R.B., Lippman M.E. Growth factors in breast cancer. Endocr Rev 1995, 16:559-589.
20. Elenbaas B., Spirio L., Koerner F., et al. Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells. Genes Dev 2001, 15:50-65.
21. Enegd B., King J.A., Stylli S., et al. Overexpression of hyaluronan synthase-2 reduces the tumorigenic potential of glioma cells lacking hyaluronidase activity. Neurosurgery 2002, 50:1311-1318.
22. Entwistle J., Hall C.L., Turley E.A. HA receptors: regulators of signalling to the cytoskeleton. J Cell Biochem 1996, 61:569-577.
23. Evanko S.P., Tammi M.I., Tammi R.H., Wight T.N. Hyaluronan-dependent pericellular matrix. Adv Drug Deliv Rev 2007, 59:1351-1365.
24. Fieber C., Baumann P., Vallon R., et al. Hyaluronan-oligosaccharide-induced transcription of metalloproteases. J Cell Sci 2004, 117:359-367.
25. Folkman J. Role of angiogenesis in tumor growth and metastasis. Semin Oncol 2002, 29:15-18.
26. Fraser J.R., Laurent T.C., Laurent U.B. Hyaluronan: its nature, distribution, functions and turnover. J Intern Med 1997, 242:27-33.
27. Fraser J.R., Laurent T.C., Engström-Laurent A., Laurent U.G. Elimination of hyaluronic acid from the blood stream in the human. Clin Exp Pharmacol Physiol 1984, 11:17-25.
28. Frisch S.M. Tumor suppression activity of adenovirus E1a protein: anoikis and the epithelial phenotype. Adv Cancer Res 2001, 80:39-49.
29. Frost G.I., Csoka T.B., Wong T., Stern R. Purification, cloning, and expression of human plasma hyaluronidase. Biochem Biophys Res Commun 1997, 236:10-15.
30. Gao F.Z.L., Underhill C.B. Promotion of growth of human breast cancer cells MDA231 by human sperm membrane-bound hyaluronidase: an experimental study. Zhonghua Yi Xue Za Zhi 2002, 82:207-210.
31. Ghatak S., Misra S., Toole B.P. Hyaluronan oligosaccharides inhibit anchorage-independent growth of tumor cells by suppressing the phosphoinositide 3-kinase/Akt cell survival pathway. J Biol Chem 2002, 277:38013-38020.
32. Goentzel B.J., Weigel P.H., Steinberg R.A. Recombinant human hyaluronan synthase 3 is phosphorylated in mammalian cells. Biochem J 2006, 396:347-354.
33. Gottfried E., Kreutz M., Haffner S., et al. Differentiation of human tumour-associated dendritic cells into endothelial-like cells: an alternative pathway of tumour angiogenesis. Scand J Immunol 2008, 65:329-335.
34. Guise T.A., Yin J.J., Taylor S.D., et al. Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis. J Clin Invest 1996, 98:1544-1549.
35. Haylock D.N., Nilsson S.K. The role of hyaluronic acid in hemopoietic stem cell biology. Regen Med 2006, 1:437-445.
36. Heldermon C., DeAngelis P.L., Weigel P.H. Topological organization of the hyaluronan synthase from Streptococcus pyogenes. J Biol Chem 2001, 276:2037-2046.
37. Hosono K., Nishida Y., Knudson W., et al. Hyaluronan oligosaccharides inhibit tumorigenicity of osteosarcoma cell lines MG-63 and LM-8 in vitro and in vivo via perturbation of hyaluronan-rich pericellular matrix of the cells. Am J Pathol 2007, 171:274-286.
38. Howlett A.R., Bissell M.J. The influence of tissue microenvironment (stroma and extracellular matrix) on the development and function of mammary epithelium. Epithelial Cell Biol 1993, 2:79-89.
39. Hu M., Polyak K. Microenvironmental regulation of cancer development. Curr Opin Genet Dev 2008, 18:27-34.
40. Itano N., Sawai T., Atsumi F., et al. Selective expression and functional characteristics of three mammalian hyaluronan synthases in oncogenic malignant transformation. J Biol Chem 2004, 279:18679-18687.
41. Itano N., Kimata K. Mammalian hyaluronan synthases. IUBMB Life 2002, 54:195-199.
42. Itano, N., Sawai, T., Yoshida, M., et al. (1999a). Three isoforms of mammalian hyaluronan synthases have distinct enzymatic properties. J Biol Chem274, 25085-25092.
43. Itano, N., Sawai, T., Miyaishi, O. and Kimata, K. (1999b). Relationship between hyaluronan production and metastatic potential of mouse mammary carcinoma cells. Cancer Res59, 2499-2504.
44. Jacobson A., Brinck J., Briskin M.J., Spicer A.P., Heldin P. Expression of human hyaluronan synthases in response to external stimuli. Biochem J 2000, 348:29-35.
45. Jones C., Nonni A.V., Fulford L., et al. CGH analysis of ductal carcinoma of the breast with basaloid/myoepithelial cell differentiation. Br J Cancer 2001, 85:422-427.
46. Karihtala P., Soini Y., Auvinen P., et al. Hyaluronan in breast cancer: correlations with nitric oxide synthases and tyrosine nitrosylation. J Histochem Cytochem 2007, 55:1191-1198.
47. Kass L., Erler J.T., Dembo M., Weaver V.M. Mammary epithelial cell: influence of extracellular matrix composition and organization during development and tumorigenesis. Int J Biochem Cell Biol 2007, 39:1987-1994.
48. Knudson W., Chow G., Knudson C.B. CD44-mediated uptake and degradation of hyaluronan. Matrix Biol 2002, 21:15-23.
49. Kobayashi H., Suzuki M., Kanayama N., et al. CD44 stimulation by fragmented hyaluronic acid induces upregulation of urokinase-type plasminogen activator and its receptor and subsequently facilitates invasion of human chondrosarcoma cells. Int J Cancer 2002, 102:378-379.
50. Koyama H., Hibi T., Isogai Z., et al. Hyperproduction of hyaluronan in neu-induced mammary tumor accelerates angiogenesis through stromal cell recruitment: possible involvement of versican/PG-M. Am J Pathol 2007, 170:1086-1099.
51. Kuang D.M., Chen N., Cheng J., Zhuang S.M., Zheng L. Tumor-derived hyaluronan induces formation of immunosuppressive macrophages through transient early activation of monocytes. Blood 2007, 110:587-595.
52. Lepperdinger G., Mullegger J., Kreil G. HYAL-2-less active, but more versatile?. Matrix Biol 2001, 20:509-514.
53. Lepperdinger G., Strobl B., Kreil G. HYAL-2, a human gene expressed in many cells, encodes a lysosomal hyaluronidase with a novel type of specificity. J Biol Chem 1998, 273:22466-22470.
54. Li Y., Li L., Brown T.J., Heldin P. Silencing of hyaluronan synthase 2 suppresses the malignant phenotype of invasive breast cancer cells. Int J Cancer 2007, 120:2557-2567.
55. Liu D.P.E., Diaconu E., Guo K., et al. Expression of hyaluronidase by tumor cells induces angiogenesis in vivo. Proc Natl Acad Sci USA 1996, 93:7832-7837.
56. Lokeshwar V.B., Selzer M.G. Differences in hyaluronic acid-mediated functions and signaling in arterial, microvessel, and vein-derived human endothelial cells. J Biol Chem 2000, 275:27641-27649.
57. Madan A.K., Dhurandhar K.Y.N., Cullinane C., Pang Y., Beech D.J. Association of hyaluronidase and breast adenocarcinoma invasiveness. Oncol Rep 1999, 6:607-609.
58. Mascarenhas M.M., Day R.M., Ochoa C.D., et al. Low molecular weight hyaluronan from stretched lung enhances interleukin-8 expression. Am J Respir Cell Mol Biol 2004, 30:51-60.
59. Mastro A.M., Gay C.V., Welch D.R., et al. Breast cancer cells induce osteoblast apoptosis: a possible contributor to bone degradation. J Cell Biochem 2004, 91:265-276.
60. Mercer R.R., Miyasaka C., Mastro A.M. Metastatic breast cancer cells suppress osteoblast adhesion and differentiation. Clin Exp Met 2004, 21:427-435.
61. Noble P.W. Hyaluronan and its catabolic products in tissue injury and repair. Matrix Biol 2002, 21:25-29.
62. Oguchi T., Ishiguro N. Differential stimulation of three forms of hyaluronan synthase by TGF-beta, IL-1beta, and TNF-alpha. Connect Tissue Res 2004, 45:197-205.
63. Orimo A., Gupta P.B., Sgroi D.C., et al. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 2005, 121:335-348.
64. Ouskova G., Spellerberg B., Prehm P. Hyaluronan release from Streptococcus pyogenes: export by an ABC transporter. Glycobiology 2004, 14:931-938.
65. Pederson L., Winding B., Foged N.T., Spelsberg T.C., Oursler M.J. Identification of breast cancer cell line-derived paracrine factors that stimulate osteoclast activity. Cancer Res 1999, 59:5849-5855.
66. Prehm P. Synthesis of hyaluronate in differentiated teratocarcinoma cells. Mechanism of chain growth. Biochem J 1983, 211:191-198.
67. Prehm P. Biosynthesis of hyaluronan: direction of chain elongation. Biochem J 2006, 398:469-473.
68. Prehm P., Schumacher U. Inhibition of hyaluronan export from human fibroblasts by inhibitors of multidrug resistance transporters. Biochem Pharmacol 2004, 68:1401-1410.
69. Prevo R., Banerji S., Ferguson D.J., Clasper S., Jackson D.G. Mouse LYVE-1 is an endocytic receptor for hyaluronan in lymphatic endothelium. J Biol Chem 2001, 276:19420-19430.
70. Rai S.K., Vigdorovich V., Danilkovitch-Miagkova A., Lerman M.I., Miller A.D. Candidate tumor suppressor HYAL-2 is a glycosylphosphatidylinositol (GPI)-anchored cell-surface receptor for jaagsiekte sheep retrovirus, the envelope protein of which mediates oncogenic transformation. Proc Natl Acad Sci USA 2001, 98:4443-4448.
71. Recklies A.D., White C., Melching L., Roughley P.J. Differential regulation and expression of hyaluronan synthases in human articular chondrocytes, synovial cells and osteosarcoma cells. Biochem J 2001, 354:17-24.
72. Rodríguez-Pinilla S.M., Rodríguez-Gil Y., Moreno-Bueno G., et al. Sporadic invasive breast carcinomas with medullary features display a basal-like phenotype: an immunohistochemical and gene amplification study. Am J Surg Pathol 2007, 31:501-508.
73. Ronnov-Jessen L., Petersen O.W., Bissell M.J..Cellular changes involved in conversion of normal to malignant breast, importance of the stromal reaction. Physiol Rev 1996, 76:69-125.
74. Rooney P., Kumar S., Ponting J., Wang M. The role of hyaluronan in tumour neovascularization (review). Int J Cancer 1995, 60:632-636.
75. Rooney P., Wang M., Kumar P., Kumar S. Angiogenic oligosaccharides of hyaluronan enhance the production of collagens by endothelial cells. J Cell Sci 1993, 105:213-218.
76. Ruibal A., Arias J., Del Río M.C., Resino C., Tejerina A. Infiltrating ductal carcinomas of the breast in women over 60 years of age. Association with higher cellular proliferation and lower PS2, cell surface and cytosolic hyaluronic acid concentrations. Rev Esp Med Nucl 2001, 20:525-529.
77. Ruibal A., Arias J.I., Carmen del Río M., et al. The cytosolic hyaluronic acid level defines several clinico-biological properties of CD44v5-positive infiltrating ductal carcinoma of the breast. Med Clin (Barc) 2000, 115:201-207.
78. Ruibal A., Arias J.I., Del Río M.C., et al. Histological grade in breast cancer: association with clinical and biological features in a series of 229 patients. Int J Biol Markers 2001, 16:56-61.
79. Sattar A., Rooney P., Kumar S. Application of angiogenic oligosaccharides of hyaluronan increases blood vessel numbers in rat skin. J Invest Dermatol 1994, 103:576-579.
80. Senger D.R., Ledbetter S.R., Claffey K.P., et al. Stimulation of endothelial cell migration by vascular permeability factor/vascular endothelial growth factor through cooperative mechanisms involving the alphavbeta3 integrin, osteopontin, and thrombin. Am J Pathol 1996, 149:293-305.
81. Slevin M., Krupinski J., Kumar S., Gaffney J. Angiogenic oligosaccharides of hyaluronan induce protein tyrosine kinase activity in endothelial cells and activate a cytoplasmic signal transduction pathway resulting in proliferation. Lab Invest 1998, 78:987-1003.
82. Slevin M., Kumar S., Gaffney J. Angiogenic oligosaccharides of hyaluronan induce multiple signaling pathways affecting vascular endothelial cell mitogenic and wound healing responses. J Biol Chem 2002, 277:41046-41059.
83. Slevin M., West D., Kumar P., Rooney P., Kumar S. Hyaluronan, angiogenesis and malignant disease. Int J Cancer 2004, 109:793-794.
84. Sørlie T., Perou C.M., Tibshirani R., et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 2001, 98:10869-10874.
85. Spicer A.P., Kaback L.A., Smith T.J., Seldin M.F. Molecular cloning and characterization of the human and mouse UDP-glucose dehydrogenase genes. J Biol Chem 1998, 273:25117-25124.
86. Stern R. Devising a pathway for hyaluronan catabolism: are we there yet?. Glycobiology 2003, 13:105R-115R.
87. Stern R. Hyaluronan metabolism: a major paradox in cancer biology. Pathol Biol (Paris) 2005, 53:372-382.
88. Stern R., Asari A.A., Sugahara K.N. Hyaluronan fragments: an information-rich system. Eur J Cell Biol 2006, 85:699-715.
89. Sugahara K.N., Hirata T., Hayasaka H., et al. Tumor cells enhance their own CD44 cleavage and motility by generating hyaluronan fragments. J Biol Chem 2006, 281:5861-5868.
90. Sugahara K.N., Murai T., Nishinakamura H., et al. Hyaluronan oligosaccharides induce CD44 cleavage and promote cell migration in CD44-expressing tumor cells. J Biol Chem 2003, 278:32259-32265.
91. Takahashi Y., Li L., Kamiryo M., et al. Hyaluronan fragments induce endothelial cell differentiation in a CD44-and CXCL1/GRO1-dependent manner. J Biol Chem 2005, 280:24195-241204.
92. Tammi R., Pienimaki D.K., MacCallum M., et al. Hyaluronan enters keratinocytes by a novel endocytic route for catabolism. J Biol Chem 2001, 276:35111-35122.
93. Thiery J.P., Sleeman J.P. Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol 2006, 7:131-142.
94. Thomas R.J., Guise T.A., Yin J.J., et al. Breast cancer cells interact with osteoblasts to support osteoclast formation. Endocrinology 1999, 140:4451-4458.
95. Tlsty T.D., Hein P.W. Know thy neighbor: stromal cells can contribute oncogenic signals. Curr Opin Genet Dev 2001, 11:54-59.
96. Toole B.P. Hyaluronan promotes the malignant phenotype. Glycobiology 2002, 12:37R-42R.
97. Toole B.P. Hyaluronan: from extracellular glue to pericellular cue. Nat Rev Cancer 2004, 4:528-539.
98. Toole B.P., Hascall V.C. Hyaluronan and tumor growth. Am J Pathol 2002, 161:745-747.
99. Tuck A.B., Elliott B.E., Hota C., Tremblay E., Chambers A.F. Osteopontin-induced, integrin-dependent migration of human mammary epithelial cells involves activation of the hepatocyte growth factor receptor (Met). J Cell Biochem 2000, 78:465-475.
100. Udabage, L., Brownlee, G.R., Nilsson, S.K. and Brown, T.J. (2005a). The over-expression of HAS-2, HYAL-2 and CD44 is implicated in the invasiveness of breast cancer. Exp Cell Res310, 205-217.
101. Udabage, L., Brownlee, G.R., Waltham, M., et al. (2005b). Antisense-mediated suppression of hyaluronan synthase 2 inhibits the tumorigenesis and progression of breast cancer. Cancer Res65, 6139-6150.
102. Vignal P., Meslet M.R., Roméo J.M., Feuilhade F. Sonographic morphology of infiltrating breast carcinoma: relationship with the shape of the hyaluronan extracellular matrix. J Ultrasound Med 2002, 21:532-538.
103. Vogelstein B.K.K. Cancer genes and the pathways they control. Nature Med 2004, 10:789-799.
104. Von Marschall Z., Scholz A., Stacker S.A., et al. Vascular endothelial growth factor-D induces lymphangiogenesis and lymphatic metastasis in models of ductal pancreatic cancer. Int J Oncol 2005, 27:669-679.
105. Wang L.P., Ning H.Y., Yang S.M., et al. Expression of PH-20 in primary and metastatic breast cancer and its pathological significance. Zhonghua Bing Li Xue Za Zhi 2004, 33:320-323.
106. Weigel P.H., DeAngelis P.L. Hyaluronan synthases: a decade-plus of novel glycosyltransferases. J Biol Chem 2007, 282:36777-36781.
107. Weigel P.H., Kyossev Z., Torres L.C. Phospholipid dependence and liposome reconstitution of purified hyaluronan synthase. J Biol Chem 2006, 281:36542-36551.
108. Wernicke M., Piñeiro L.C., Caramutti D., et al. Breast cancer stromal myxoid changes are associated with tumor invasion and metastasis: a central role for hyaluronan. Mod Pathol 2003, 16:99-107.
109. West D.C., Kumar S. The effect of hyaluronate and its oligosaccharides on endothelial cell proliferation and monolayer integrity. Exp Cell Res 1989, 183:179-196.
110. West D.C., Hampson I.N., Arnold F., Kumar S. Angiogenesis induced by degradation products of hyaluronic acid. Science 1985, 228:1324-1326.
111. Zoltan-Jones A., Huang L., Ghatak S., Toole B.P. Elevated hyaluronan production induces mesenchymal and transformed properties in epithelial cells. J Biol Chem 2003, 278:45801-45810.